全身性念珠菌感染则需要使用如氟康唑、酮康唑、伊曲康唑或两性霉素等全身性抗真菌药物进行治疗。
Systemic candidiasis requires treatment with systemic antifungal agents such as fluconazole, ketoconazole, itraconazole or amphotericin.
结论：伊曲康唑固体分散体能明显提高伊曲康唑的溶解度及体外溶出速率。
CONCLUSION Itraconazole solid dispersion can significantly increase it's solubility and dissolution rate.
目的比较特比萘芬与伊曲康唑、氟康唑、灰黄霉素治疗甲癣疗效的差异。
Objective To compare the efficacy of terbinafine with itraconazole, fluconazole and griseofulvin in the treatment of dermatophyte onychomycosis.
目的研究伊曲康唑脂质体体外抗深部真菌作用。
OBJECTIVE To study the antifungal activity of Itraconazole Liposome in vitro.
目的：比较特比萘芬片剂和伊曲康唑胶囊治疗甲真菌病的有效性和安全性。
AIM: To compare the efficacy and safety of terbinafine and intraconazole in the treatment of onychomycosis.
目的：观察伊曲康唑治疗甲真菌病的疗效、安全性及对甲生长速度的影响。
Objective: To observe the efficacy and safety of itraconazole in treatment of onychomycosis and its influence on nail growth speed.
目的研究伊曲康唑治疗对甲真菌病患者生活质量的影响。
Objective To investigate the influence of itraconazole therapy on the quality of life of patients with onychomycosis.
结论：伊曲康唑预防性治疗能有效地阻止RVVC的复发。
Conclusion: Prophylactic treatment by Iraconazole can prevent the relapse of RVVC efficiently.
伊曲康唑是治疗甲癣较理想的药物。
Conclusion Itraconazole was an effective medicine to treat Onychomycosis.
目的评价甲真菌病临床评分指数(SCIO)指导伊曲康唑冲击和特比萘芬连续疗法治疗甲真菌病的疗效、安全性及费用疗效比。
Objective To assess the efficacy, safety and cost-effectiveness of itraconazole and terbinafine for the treatment of onychomycosis, evaluated by the scoring clinical index of onychomycosis (SCIO).
体外药敏试验显示对伊曲康唑、两性霉素B、制霉菌素高度敏感，酮康唑、克霉唑低度敏感，氟康唑耐药。
The drug sensitive test in vitro indicated that itraconazole, amphotericin B and nystatin were highly sensitive, ketoconazole and clotrimazole were low sensitive, fluconazole was resistant.
目的研究伊曲康唑自乳化胶囊的处方并考察其溶出度。
OBJECTIVE To study the formulation of itraconazole self-emulsifying capsule and its dissolution property.
目的研究伊曲康唑治疗恶性血液病合并侵袭性真菌感染的疗效。
Objective to investigate the efficacy of itraconazole in the treatment of malignant hematological diseases with invasive fungal infections.
结论：伊曲康唑治疗国人浅表念珠菌感染安全有效，不良反应发生率较低。
Conclusions: Itraconazole is an effective and safe antimycotics in the treatment of superficial Candidal infections in China.
目的评估伊曲康唑注射液治疗侵袭性真菌感染的肝脏安全性。
Objective To investigate the hepatic safety of itraconazole intravenous solution in the treatment of invasive fungal infection.
伊曲康唑为三唑类广谱抗真菌药，对浅表真菌、深部真菌感染均有显著疗效，且耐受性良好，临床应用广泛。
Itraconazole, a triazole broad-spectrum antifungal drug, is notably effective on superficial and deep fungal infection, and widely used with good tolerance.
分别采用两性霉素B、两性霉素B脂质体、伊曲康唑全身用药，结合支气管镜腔内局部治疗，有效率为47.4%。
The patients were treated with amphotericin B, amphotericin B liposome or itraconazole intravenously in combination with therapy intraluminally with bronchoscope. The efficacy rate was 47.4%.
对GM实验阳性的患者给予两性霉素B或伊曲康唑抢先抗曲霉治疗。
Furthermore, the patients with positive GM test received preemptive antifungal therapy with amphotericin B or itraconazole.
评估伊曲康唑治疗ICU中危重患者侵袭性真菌感染（IFI）的疗效及安全性。
To evaluate the efficacy and safety of itraconazloe in treating the invasive fugal infection(IFI) in ICU.
结论伊曲康唑治疗丘疹型皮肤念珠菌值得临床应用。
Conclusion We found that itraconazole would be worth exploring in treatment of papule type cutaneous moniliasis.
目的：评价静脉滴注伊曲康唑防治兔侵袭性曲霉病的价值。
Objective: To investigate the efficacy of intravenous itraconazole in the treatment and prophylaxis of invasive aspergillosis.
经验性治疗患者伊曲康唑静脉给药。
For the empirical treatment patients, only intravenous itraconazole was given.
经伊曲康唑、制霉菌素等药治疗后，皮损逐渐好转。
After treatment with itraconazole and nystatin, the lesion recovered gradually.
目的：观察伊曲康唑对银屑病的疗效。
AIM: To assess the therapeutic effect of itraconazole in treating psoriasis.
对氟康唑耐药的9株菌株也同时对伊曲康唑耐药。
The 9 isolates resistant to fluconazole were cross resistant to itraconazole.
口服伊曲康唑和5氟胞嘧啶有明显效果。
The patient received oral itraconazole and 5 FC and showed favorable effect.
建立了盐酸伊曲康唑胶囊溶出度的紫外分光光度测定法。
The dissolution test for itraconazole hydrochloride capsules by UV spectrometry was presented.
预防性静脉滴注伊曲康唑组其血清GM含量和组织真菌负荷量比对照组明显降低。
Serum GM index and fungal CFU in tissues were also markedly reduced in prophylactic itraconzole group.
经口服伊曲康唑等药物治疗皮疹基本消退。
The lesions dissipated after treatment with oral itraconazole.
本发明提供吡咯抗微生物药物诸如伊曲康唑、沙康唑、酮康唑和氟 康唑的口服药物制剂。
The present invention provides oral pharmaceutical formulation for azole antimicrobial drugs such as itraconazole, saperconazole, ketoconazole, and fluconazole.
应用推荐